In bronchopulmonary tissue, PM2.5 can stimulate kallikrein expression and the release of bradykinin (BK), and kallikrein inhibitors can reverse these alterations, demonstrating that kallikrein is relevant in PM2.5-induced airway hyperresponsiveness (17). This evidence concerns the gene KLK4 and airway hyperresponsiveness.